{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:28:58Z","timestamp":1788870538876,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["R-397-000-117-112"],"award-info":[{"award-number":["R-397-000-117-112"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.biomaterials.2013.03.029","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T06:36:02Z","timestamp":1364884562000},"page":"4860-4871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Targeting CCL21\u2013folic acid\u2013upconversion nanoparticles conjugates to folate receptor-\u03b1 expressing tumor cells in an endothelial-tumor cell bilayer model"],"prefix":"10.1016","volume":"34","author":[{"given":"Kim Yee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaw Chyn","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.03.029_bib1","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1038\/onc.2008.268","article-title":"How tumours escape mass destruction","volume":"27","author":"Stewart","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10555-011-9280-5","article-title":"Improving cancer immunotherapy by targeting tumor-induced immune suppression","volume":"30","author":"Stewart","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nri748","article-title":"Chemokines: agents for the immunotherapy of cancer?","volume":"2","author":"Homey","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2217\/imt.11.115","article-title":"Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors","volume":"3","author":"Lechner","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/intimm\/dxq435","article-title":"Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration","volume":"22","author":"Johnson","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"Forster","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib9","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1371\/journal.pbio.0030150","article-title":"Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells","volume":"3","author":"Okada","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib11","first-page":"4558","article-title":"Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in\u00a0vivo","volume":"164","author":"Sharma","year":"2000","journal-title":"J\u00a0Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib12","doi-asserted-by":"crossref","first-page":"e18758","DOI":"10.1371\/journal.pone.0018758","article-title":"Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth","volume":"6","author":"Kar","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.18388\/abp.2000_3992","article-title":"Cellular aspects of folate and antifolate membrane transport","volume":"47","author":"Brzezinska","year":"2000","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0083-6729(03)01012-4","article-title":"Membrane transport of folates","author":"Matherly","year":"2003","journal-title":"Vitam Horm"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.nutr.19.1.91","article-title":"Carrier-mediated membrane transport of folates in mammalian cells","volume":"19","author":"Sirotnak","year":"1999","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib16","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood.V79.11.2807.2807","article-title":"The biological chemistry of folate receptors","volume":"79","author":"Antony","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","article-title":"Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy","volume":"56","author":"Elnakat","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib18","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S","article-title":"Differential regulation of folate receptor isoforms in normal and malignant tissues in\u00a0vivo and in established cell lines. Physiologic and clinical implications","volume":"73","author":"Ross","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib19","first-page":"557","article-title":"Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein","volume":"142","author":"Garin-Chesa","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib20","first-page":"69","article-title":"Folate as a targeting device for proteins utilizing folate receptor-mediated endocytosis","volume":"25","author":"Lee","year":"2000","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib21","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1021\/cr900362e","article-title":"Lanthanide luminescence for biomedical analyses and imaging","volume":"110","author":"B\u00fcnzli","year":"2010","journal-title":"Chem Rev"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib22","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1021\/nn202378b","article-title":"Biological applications of rare-earth based nanoparticles","volume":"5","author":"Bouzigues","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib23","doi-asserted-by":"crossref","first-page":"345606","DOI":"10.1088\/0957-4484\/19\/34\/345606","article-title":"An efficient and user-friendly method for the synthesis of hexagonal-phase NaYF 4 :Yb, Er\/Tm nanocrystals with controllable shape and upconversion fluorescence","volume":"19","author":"Li","year":"2008","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib24","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/smll.200900692","article-title":"Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy","volume":"5","author":"Qian","year":"2009","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/nm.2933","article-title":"In\u00a0vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers","volume":"18","author":"Idris","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib26","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1039\/b925137e","article-title":"Fabrication of mesoporous silica-coated CNTs and application in size-selective protein separation","volume":"20","author":"Zhang","year":"2010","journal-title":"J\u00a0Mater Chem"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib27","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1039\/c0an00144a","article-title":"Upconversion nanoparticles in biological labeling, imaging, and therapy","volume":"135","author":"Wang","year":"2010","journal-title":"Analyst"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib28","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1039\/c2nr31570j","article-title":"Upconversion nanoparticles for sensitive and in-depth detection of Cu2+ ions","volume":"4","author":"Li","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2004.12.010","article-title":"Poly(ethylene oxide)-modified poly(\u025b-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer","volume":"293","author":"Shenoy","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1083\/jcb.134.5.1169","article-title":"Clustered folate receptors deliver 5-methyltetrahydrofolate to cytoplasm of MA104 cells","volume":"134","author":"Smart","year":"1996","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cbpa.2009.03.022","article-title":"Folate-targeted therapeutic and imaging agents for cancer","volume":"13","author":"Low","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10456-012-9289-6","article-title":"Folic acid inhibits\u00a0endothelial cell proliferation through activating the cSrc\/ERK 2\/NF-\u03baB\/p53 pathway mediated by folic acid receptor","volume":"15","author":"Lin","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/bdra.20581","article-title":"Folic acid, methylation and neural tube closure in humans","volume":"85","author":"Blom","year":"2009","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib35","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1021\/bi00016a042","article-title":"Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity","volume":"34","author":"Shen","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ncb1486","article-title":"VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin","volume":"8","author":"Gavard","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.drudis.2006.07.005","article-title":"Exploiting the enhanced permeability and retention effect for tumor targeting","volume":"11","author":"Iyer","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib39","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.biomaterials.2013.03.029_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J\u00a0Control Release"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213003268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213003268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:49:30Z","timestamp":1758901770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961213003268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":40,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0142961213003268"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.03.029","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting CCL21\u2013folic acid\u2013upconversion nanoparticles conjugates to folate receptor-\u03b1 expressing tumor cells in an endothelial-tumor cell bilayer model","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}